Mostrar el registro sencillo del ítem

dc.contributor.authorChapa, Christian
dc.date.accessioned2023-05-03T19:05:36Z
dc.date.available2023-05-03T19:05:36Z
dc.date.issued2023-02-15es_MX
dc.identifier.urihttp://cathi.uacj.mx/20.500.11961/25584
dc.description.abstractObjectives Lipid nanoparticles, as a nucleic acid delivery system, have been used as an alternative to treat ocular diseases, since they can cross the ocular barrier and efficiently transfecting nucleic acids to various cells of the eye. The size influences the transfection of genes, biological distribution, diffusion, and cellular uptake. It is therefore important to establish a relationship between size, formulation, and encapsulation percentage. Evidence acquisition In this review, we used a search strategy to compare studies of nanomedicine systems aimed at eye diseases where the size of the nanoparticles and the efficiency of encapsulation of genetic material are reported based on the criteria of Preferred Reporting Items for Systematic Reviews (PRISMA ScR 2020 guidelines). Results Out of the initial 5932, 169 studies met the inclusion criteria and were included to form the basis of the analysis. Nanoparticles reported are composed mainly of PEG-modified lipids, cholesterol, and cationic lipids, that in combination with messenger or interference RNA, allow the formulation of a nanoparticle with an encapsulation efficiency greater than 95%. The diseases treated mainly focus on conditions related to the retina and cornea. Certain characteristics of nanoparticles increase encapsulation efficiency, such as the size of the nanoparticle and the charge of the outer layer of the nanoparticle. Conclusion It is still unknown what characteristics lipid nanoparticles should have to successfully treat human eye illnesses. The in vitro and in vivo investigations covered in this review, however, present encouraging results. To improve encapsulation effectiveness and disease gene silencing, nanoparticle formulation is essential. The most stable nanoparticles are those made mostly of cationic lipids, PEG lipids, and cholesterol, which also effectively encapsulate RNA. The encapsulation efficiency is not only influenced by size, but also by other factors such as methods of preparation.es_MX
dc.description.urihttps://link.springer.com/article/10.1007/s40199-023-00455-1es_MX
dc.language.isoenes_MX
dc.relation.ispartofProducto de investigación IITes_MX
dc.relation.ispartofInstituto de Ingeniería y Tecnologíaes_MX
dc.subjectNanoparticleses_MX
dc.subjectDelivery systemes_MX
dc.subjectLipides_MX
dc.subjectEyees_MX
dc.subjectEncapsulationes_MX
dc.subjectNucleic acides_MX
dc.subject.otherinfo:eu-repo/classification/cti/2es_MX
dc.subject.otherinfo:eu-repo/classification/cti/3es_MX
dc.subject.otherinfo:eu-repo/classification/cti/7es_MX
dc.titleLipid nanoparticles for gene therapy in ocular diseaseses_MX
dc.typeArtículoes_MX
dcterms.thumbnailhttp://ri.uacj.mx/vufind/thumbnails/rupiiit.pnges_MX
dcrupi.institutoInstituto de Ingeniería y Tecnologíaes_MX
dcrupi.cosechableSies_MX
dcrupi.volumen31es_MX
dcrupi.nopagina1-8es_MX
dc.identifier.doihttps://doi.org/10.1007/s40199-023-00455-1es_MX
dc.contributor.coauthorOlivas Armendariz, Imelda
dc.contributor.alumno168456es_MX
dc.journal.titleDARU, Journal of Pharmaceutical Scienceses_MX
dc.contributor.authorexternoRoacho Pérez, Jorge Alberto
dcrupi.pronacesSaludes_MX


Archivos en el ítem

Thumbnail
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem


Av. Plutarco Elías Calles #1210 • Fovissste Chamizal
Ciudad Juárez, Chihuahua, México • C.P. 32310 • Tel. (+52) 688 – 2100 al 09